Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

VLDL Cholesterol Accounts for One-Half of the Risk of Myocardial Infarction Associated With apoB-Containing Lipoproteins
Mie Balling, Shoaib Afzal, Anette Varbo, et al.
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 23, pp. 2725-2735
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society
Henry N. Ginsberg, Chris J. Packard, M. John Chapman, et al.
European Heart Journal (2021) Vol. 42, Iss. 47, pp. 4791-4806
Open Access | Times Cited: 524
Association of Apolipoprotein B–Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis
Nicholas Marston, Robert P. Giugliano, Giorgio Melloni, et al.
JAMA Cardiology (2021) Vol. 7, Iss. 3, pp. 250-250
Open Access | Times Cited: 171
Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: a cohort-based study
Benjamin Nilsson Wadström, Anders Berg Wulff, Kasper Mønsted Pedersen, et al.
European Heart Journal (2021) Vol. 43, Iss. 34, pp. 3258-3269
Closed Access | Times Cited: 149
Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
Jean‐Claude Tardif, Ewa Karwatowska‐Prokopczuk, Eric St Amour, et al.
European Heart Journal (2021) Vol. 43, Iss. 14, pp. 1401-1412
Open Access | Times Cited: 147
Coronary heart disease risk: Low-density lipoprotein and beyond
Gabriel E. Shaya, Thorsten M. Leucker, Steven R. Jones, et al.
Trends in Cardiovascular Medicine (2021) Vol. 32, Iss. 4, pp. 181-194
Closed Access | Times Cited: 140
Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia
Jan Borén, Marja‐Riitta Taskinen, Elias Björnson, et al.
Nature Reviews Cardiology (2022) Vol. 19, Iss. 9, pp. 577-592
Closed Access | Times Cited: 140
Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets
Chen Wang, Zhelong Li, Yunnan Liu, et al.
Theranostics (2021) Vol. 11, Iss. 8, pp. 3996-4010
Open Access | Times Cited: 122
Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, et al.
European Heart Journal (2023) Vol. 44, Iss. 16, pp. 1432-1445
Closed Access | Times Cited: 93
Hegemony of inflammation in atherosclerosis and coronary artery disease
Ali Attiq, Sheryar Afzal, Waqas Ahmad, et al.
European Journal of Pharmacology (2024) Vol. 966, pp. 176338-176338
Open Access | Times Cited: 55
Associations between types and sources of dietary carbohydrates and cardiovascular disease risk: a prospective cohort study of UK Biobank participants
Rebecca K. Kelly, Tammy Y. N. Tong, Cody Z. Watling, et al.
BMC Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 45
Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk
John R. Burnett, Amanda J. Hooper, Robert A. Hegele
Journal of the American College of Cardiology (2020) Vol. 76, Iss. 23, pp. 2736-2739
Open Access | Times Cited: 72
Triglycerides and cardiovascular disease
Oluwayemisi Esan, Anthony S. Wierzbicki
Current Opinion in Cardiology (2021) Vol. 36, Iss. 4, pp. 469-477
Closed Access | Times Cited: 69
Obesity Affects HDL Metabolism, Composition and Subclass Distribution
Julia T. Stadler, Sonja Lackner, Sabrina Mörkl, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 242-242
Open Access | Times Cited: 58
Prioritizing the Role of Major Lipoproteins and Subfractions as Risk Factors for Peripheral Artery Disease
Michael G. Levin, Verena Zuber, Venexia Walker, et al.
Circulation (2021) Vol. 144, Iss. 5, pp. 353-364
Open Access | Times Cited: 58
Emerging Evidence of Pathological Roles of Very-Low-Density Lipoprotein (VLDL)
Jih-Kai Huang, Hsiang‐Chun Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4300-4300
Open Access | Times Cited: 54
High Remnant Cholesterol Level Potentiates the Development of Hypertension
Mingming Chen, Xuewei Huang, Chengsheng Xu, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 38
ANGPTL3 inhibition, dyslipidemia, and cardiovascular diseases
Fei Luo, Avash Das, Sumeet A. Khetarpal, et al.
Trends in Cardiovascular Medicine (2023) Vol. 34, Iss. 4, pp. 215-222
Open Access | Times Cited: 32
Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence
Salman Zahoor Bhat, Sudipa Sarkar, Duha Zaffar, et al.
Current Cardiology Reports (2023) Vol. 25, Iss. 2, pp. 51-65
Closed Access | Times Cited: 29
Remnant cholesterol, low-density lipoprotein cholesterol, and incident cardiovascular disease among Koreans: a national population-based study
Sang Jun Lee, Se-Eun Kim, Tae‐Hwa Go, et al.
European Journal of Preventive Cardiology (2023) Vol. 30, Iss. 11, pp. 1142-1150
Closed Access | Times Cited: 28
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease
Om P Ganda
Current Opinion in Lipidology (2023) Vol. 34, Iss. 3, pp. 105-113
Closed Access | Times Cited: 28
Triglyceride-Rich Lipoproteins and Remnant Cholesterol in Cardiovascular Disease
Ji Hye Heo, Sang‐Ho Jo
Journal of Korean Medical Science (2023) Vol. 38, Iss. 38
Open Access | Times Cited: 25
Excess Apolipoprotein B and Cardiovascular Risk in Women and Men
Camilla Ditlev Lindhardt Johannesen, Anne Langsted, Børge G. Nordestgaard, et al.
Journal of the American College of Cardiology (2024) Vol. 83, Iss. 23, pp. 2262-2273
Closed Access | Times Cited: 13
Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets
Jingfei Chen, Zhenfei Fang, Qin Luo, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Association of remnant cholesterol with decreased kidney function or albuminuria: a population-based study in the U.S.
Xuan He, Renfang Zou, Xiaoqiong Du, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Remnant Cholesterol, Not LDL Cholesterol, Explains Peripheral Artery Disease Risk Conferred by apoB: A Cohort Study
Benjamin Nilsson Wadström, Kasper Mønsted Pedersen, Anders Berg Wulff, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 5, pp. 1144-1155
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top